Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.25.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 02, 2022
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Payments of stock issuance costs       $ 18 $ 581
Proceeds from issuance initial public offering [1],[2]       891 25,070
Share-Based Payment Arrangement, Noncash Expense   $ 433 $ 927 2,186 $ 2,877
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount   $ 2,086   $ 2,086  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition       1 year 6 months  
Risk free interest rate       4.12%  
Expected Term       6 years 6 months  
Expected volatility rate       81.00%  
Dividend yield       0.00%  
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Sale of stock consideration received on transaction       $ 909  
Sale of stock number of shares issued in transaction       681,330  
Payments of stock issuance costs       $ 18  
Proceeds from issuance initial public offering       $ 891  
Restricted Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Granted shares       1,449,696  
Aggregate grant date fair value       $ 1,525  
Award vesting rights, description       the Company granted the following awards to three executives under the Company’s Executives’ Long-Term Incentive (“LTI”) Plan equal to 50% of the executives’ annual base salary. Such awards will be issued in the form of restricted stock units. Of the RSUs granted, 50% of the restricted stock units are designated as performance-based stock awards and will vest in four equal installments upon the achievement of specified escalating stock price thresholds and 50% of the restricted stock units are designated as time-based awards and will vest in equal one-third increments on each anniversary of the grant date, in each instance subject to continued employment with the Company on the applicable vesting date and satisfying the key performance indicators and other performance criteria  
First One Fourth Vesting [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share price   $ 3.00   $ 3.00  
Second One Fourth Vesting [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share price   5.00   5.00  
Third One Fourth Vesting [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share price   7.50   7.50  
Final One Fourth Vesting [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share price   $ 9.50   $ 9.50  
Share-Based Payment Arrangement, Option [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Granted shares       63,252  
Stock Option, Exercise Price, Increase       $ 0.97  
Grant date fair value per share       $ 0.76  
Sales Agreement [Member] | Roth Capital Partners, LLC [Member] | Maximum [Member] | 2022 At The Market Offering [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Sale of stock consideration received on transaction $ 250,000        
[1] For the nine months ended September 30, 2025, includes gross proceeds of $909, less issuance costs of $18.
[2] For the nine months ended September 30, 2024, includes gross proceeds of $25,651, less issuance costs of $581.